Publications: Dr Sara Calder¿n
Calderón-Larrañaga S, Greenhalgh T, Clinch M, Robson J, Dostal I, Eto F, Finer S
(
2023
)
.
Unravelling the potential of social prescribing in individual-level type 2 diabetes prevention: a mixed-methods realist evaluation
.
BMC Medicine
vol.
21
,
(
1
)
Rodríguez Benito L, Benedé Azagra CB, Cubillo Llanes J, Calderón Larrañaga S
(
2023
)
.
Prescripción social y recomendación de activos en Atención Primaria: «el círculo de calidad»
.
Revista Clínica de Medicina de Familia
Antequera A, Cuadrado-Conde MA, Roy-Vallejo E, Montoya-Martínez M, León-García M, Madrid-Pascual O, Calderón-Larrañaga S
(
2022
)
.
Lack of sex-related analysis and reporting in Cochrane Reviews: a cross-sectional study
.
Systematic Reviews
vol.
11
,
(
1
)
Calderón-Larrañaga S
(
2022
)
.
How to make family medicine attractive to new graduates
.
FMC Formacion Medica Continuada en Atencion Primaria
vol.
29
,
(
9
)
473
-
475
.
Khalid S, Calderon-Larranaga S, Sami A, Hawley S, Judge A, Arden N, Van Staa TP, Cooper C et al.
(
2022
)
.
Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
.
Osteoporosis International
vol.
33
,
(
7
)
1579
-
1589
.
Calderón-Larrañaga S, Greenhalgh T, Finer S, Clinch M
(
2022
)
.
What does the literature mean by social prescribing? A critical review using discourse analysis
.
Sociology of Health and Illness
vol.
44
,
(
4-5
)
848
-
868
.
Calderón-Larrañaga S, Milner Y, Clinch M, Greenhalgh T, Finer S
(
2021
)
.
Tensions and opportunities in social prescribing. Developing a framework to facilitate its implementation and evaluation in primary care: a realist review
.
BJGP Open
vol.
5
,
(
3
)
1
-
13
.
Calderón-Larranãga S, Valls-Pérez B, Cardo-Miota A, Botello B, Lafuente N, Hernán M
(
2021
)
.
Development and evaluation of a training programme on asset-based community development aimed at general practice trainees: Protocol for a mixed-method multilevel and multicentric action research study
.
BMJ Open
vol.
11
,
(
5
)
Calderón Larrañaga S, Clinch M, Greenhalgh T, Finer S
(
2021
)
.
Could social prescribing contribute to type 2 diabetes prevention in people at high risk? Protocol for a realist, multilevel, mixed methods review and evaluation
.
BMJ Open
vol.
11
,
(
4
)
Calderón-Larrañaga S, Braddick F
(
2021
)
.
From social prescribing to community referrals: What works, for whom, in what context and how?
.
FMC Formacion Medica Continuada en Atencion Primaria
vol.
28
,
(
3
)
3
-
11
.
Gopal DP, Calderón-Larrañaga S
(
2021
)
.
Gut feeling is changing in the post-coronavirus world
.
British Journal of General Practice
vol.
71
,
(
702
)
24
-
24
.
Calderón Larrañaga S, Expósito Ruiz M, Cruz Vela P, Cuadrado Conde A, Alquézar Villarroya L, Garach Gómez A, Ruiz Hernández A, Toral López I
(
2019
)
.
[Primary Care and oral health promotion: Assessment of an educational intervention in school children]
.
Aten Primaria
vol.
51
,
(
7
)
416
-
423
.
Valls Pérez B, Calderón Larrañaga S, March Cerdà JC, Oltra Rodríguez E
(
2018
)
.
[Training in community health: challenges, threats and opportunities. SESPAS Report 2018]
.
Gac Sanit
vol.
32 Suppl 1
,
82
-
85
.
Khalid S, Calderon-Larrañaga S, Hawley S, Ali MS, Judge A, Arden N, van Staa T, Cooper C et al.
(
2018
)
.
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database
.
Clin Epidemiol
vol.
10
,
1417
-
1431
.
Calderón Larrañaga S, Rabanaque Hernández MJ
(
2014
)
.
[Medical students and drug marketing]
.
Aten Primaria
vol.
46
,
(
3
)
156
-
166
.